![]() Pharma Two B Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. | ![]() Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. | ![]() Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 1994 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Rehovot, IL HQ | Locations Cambridge, US HQ | Locations Alameda, US HQ | Locations Needham, US HQ Walsrode, DE |
Employees | Employees 9 | Employees 25 | Employees 1,14712% decrease | Employees 7328% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 726.1 k | Valuation ($) 8.2 b | Valuation ($) 144.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income N/A | Net income ($44.4m) (FY, 2022) | Net income $782.6m (FY, 2025) | Net income ($209.5m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 38m | Total funding raised $ 106.6m | Total funding raised N/A | Total funding raised $ 170m |

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View company
Exelixis is an oncology company that develops cancer treatments.
View company
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View company